Literature DB >> 20154266

Human CD4- 8- T cells are a distinctive immunoregulatory subset.

Mei-Chuan Huang1, Kalpesh Patel, Dennis D Taub, Dan L Longo, Edward J Goetzl.   

Abstract

Human CD4(-)8(-) T cells are a minor subset quantitatively but potentially important in immunity because they are predominantly distributed at body surfaces, and their number and activities increase in autoimmune diseases and decrease with aging. Distinguishing characteristics of CD4(-)8(-) T cells are found to include a unique profile of cytokines, including Serpin E1, which is not generated by other T cells, MIF, and TGF-beta. At 2-5% of the total in mixtures with CD4 + CD8 T cells, CD4(-)8(-) T cells enhance the generation of IFN-gamma and IL-17 by up to 12- and 5-fold, respectively, without contributing either cytokine or affecting cytokine production by NK/NKT cells. CD4(-)8(-) T cell-derived MIF is their major enhancer and TGFbeta their principal inhibitor of CD4 and CD8 T cell cytokine production. Decreases in CD4(-)8(-) T cell effects may diminish protective immunity in aging, whereas increases may augment the severity of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154266      PMCID: PMC2887271          DOI: 10.1096/fj.09-153148

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  Impaired T cell function in RANTES-deficient mice.

Authors:  Yasuhiko Makino; Donald N Cook; Oliver Smithies; Olivia Y Hwang; Eric G Neilson; Laurence A Turka; Hiroshi Sato; Andrew D Wells; Theodore M Danoff
Journal:  Clin Immunol       Date:  2002-03       Impact factor: 3.969

2.  Induction of specific tolerance by hepatic double-negative CD4-8- alpha beta T cells of mice immunized with allogeneic cells via the portal vein in vivo [corrected].

Authors:  N Koyamada; T Ohteki; T Abo; T Fukumori; N Ohkouchi; S Satomi; Y Taguchi; A Kusumi; S Mori; K Kumagai
Journal:  Cell Immunol       Date:  1993-06       Impact factor: 4.868

3.  Definition of a population of CD4-8- T cells that express the alpha beta T-cell receptor and respond to interleukins 2, 3, and 4.

Authors:  M Londei; A Verhoef; P De Berardinis; M Kissonerghis; B Grubeck-Loebenstein; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  CD4-8- T-cells increase in MRI/lpr mice treated with thymic factors.

Authors:  M Mattei; S Bach; S Di Cesare; M Fraziano; R Placido; F Poccia; I Sammarco; A M Moras; M R Bardone; V Colizzi
Journal:  Int J Immunopharmacol       Date:  1994-08

5.  Human CD4-CD8- alpha beta + T-cell receptor T cells recognize different mycobacteria strains in the context of CD1b.

Authors:  H Thomssen; J Ivanyi; C Espitia; A Arya; M Londei
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

6.  Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.

Authors:  A Anand; G S Dean; K Quereshi; D A Isenberg; P M Lydyard
Journal:  Lupus       Date:  2002       Impact factor: 2.911

7.  CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.

Authors:  S Porcelli; C T Morita; M B Brenner
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

8.  A comparative study of the characteristics of intraepithelial and lamina propria lymphocytes of the human nasal mucosa.

Authors:  R Pawankar; M Okuda
Journal:  Allergy       Date:  1993-02       Impact factor: 13.146

9.  Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells.

Authors:  Xiaohong Zhang; Hideki Fujii; Hidehiro Kishimoto; Eric LeRoy; Charles D Surh; Jonathan Sprent
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

Review 10.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

View more
  5 in total

1.  Gender specificity of altered human immune cytokine profiles in aging.

Authors:  Edward J Goetzl; Mei-Chuan Huang; Junko Kon; Kalpesh Patel; Janice B Schwartz; Katharine Fast; Luigi Ferrucci; Karen Madara; Dennis D Taub; Dan L Longo
Journal:  FASEB J       Date:  2010-05-07       Impact factor: 5.191

2.  Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Authors:  H Lim; L Kane; J B Schwartz; C S Hesdorffer; S G Deeks; N Greig; L Ferrucci; E J Goetzl
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  Defective T cell chemotaxis to sphingosine 1-phosphate and chemokine CCL21 in idiopathic T lymphocytopenia.

Authors:  Edward J Goetzl; Janice B Schwartz; Mei-Chuan Huang
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

4.  Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide.

Authors:  Mei-Chuan Huang; Nigel H Greig; Weiming Luo; David Tweedie; Janice B Schwartz; Dan L Longo; Luigi Ferrucci; William B Ershler; Edward J Goetzl
Journal:  Clin Immunol       Date:  2010-12-03       Impact factor: 3.969

5.  Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.

Authors:  Ravi Kumar; Tristan de Mooij; Timothy E Peterson; Tatiana Kaptzan; Aaron J Johnson; David J Daniels; Ian F Parney
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.